About
CD95 (also known as Fas) is a death receptor that belongs to the TNF (tumor necrosis factor) receptor superfamily. Its ligand, CD95L is a transmembrane cytokine (m-CD95L), which can be cleaved by metalloproteases and released in the bloodstream as a soluble fragment (s-CD95L). While m-CD95L is found at the surface of immune cells (T cells and NK cells) where it orchestrates the elimination of transformed/infected cells and the immune contraction, s-CD95L behaves as a proto-oncogene enhancing the risk of metastatic occurrence in breast cancers.
Our main goals are i) to decipher how CD95 switches from implementing cell death to non-apoptotic signaling pathways, ii) to identify the cells whose function is deregulated by the naturally processed ligand in breast cancer and lupus and iii) to develop original therapeutics that selectively inhibit the CD95-mediated non-apoptotic and pro-inflammatory signaling pathway.
Team info
Team name: |
Equipe Mécanismes moléculaires de la lymphomagénèse |
Affiliated team: |
No |
Website: |
https://www.unilim.fr/cribl/ |
Address: |
Rue du Dr Raymond Marcland, 87000, Limoges |
Scientific info
Research domains |
apoptose |
|
immunologie |
|
migration |
|
signalisation |
|
transduction du signal |
Organelle/Compartment |
cytosquelette: actine |
|
membrane plasmique |
Techniques |
imagerie confocale |
|
immuno-me |
|
systemes in vitro |
Cell Models |
cellules primaires |
|
lignees cellulaires |